Review of economic evidence on the impact of substandard and falsified medicines in low and middle-income countries

  • At: 2017 FIP Congress in Seoul (South Korea)
  • Type: Presentation
  • By: YEMEKE, Tatenda (United States)
  • Co-author(s): Sachiko Ozawa
    Sophia Bessias
    Deson Haynie
    Tatenda Yemeke
    Jim Herrington
  • Abstract:

    Methods

    Five databases (PubMed, EconLit, Global Health, EMBASE and SCOPUS) were searched for articles containing data on prevalence and/or economic impact of SF medicines in LMICs. Studies that did not seek to quantify the problem or that pertained only to high-income countries were excluded. Data describing setting, medicine, disease target,

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login